These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30963187)

  • 1. Pre-diagnostic plasma enterolactone concentrations are associated with lower mortality among individuals with type 2 diabetes: a case-cohort study in the Danish Diet, Cancer and Health cohort.
    Eriksen AK; Kyrø C; Nørskov NP; Frederiksen K; Bach Knudsen KE; Overvad K; Landberg R; Tjønneland A; Olsen A
    Diabetologia; 2019 Jun; 62(6):959-969. PubMed ID: 30963187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women - The Danish Diet, Cancer and Health cohort.
    Kyrø C; Hansen L; Frederiksen K; Nørskov NP; Bach Knudsen KE; Eriksen AK; Holm M; Tjønneland A; Olsen A
    Clin Nutr; 2018 Dec; 37(6 Pt A):2217-2225. PubMed ID: 29154112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediagnostic enterolactone concentrations and mortality among Danish men diagnosed with prostate cancer.
    Eriksen AK; Kyrø C; Nørskov N; Bolvig AK; Christensen J; Tjønneland A; Overvad K; Landberg R; Olsen A
    Eur J Clin Nutr; 2017 Oct; 71(10):1235-1240. PubMed ID: 28378849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediagnosis plasma concentrations of enterolactone and survival after colorectal cancer: the Danish Diet, Cancer and Health cohort.
    Kyrø C; Frederiksen K; Holm M; Nørskov NP; Knudsen KEB; Overvad K; Tjønneland A; Olsen A
    Br J Nutr; 2019 Sep; 122(5):552-563. PubMed ID: 30173678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediagnostic plasma enterolactone levels and mortality among women with breast cancer.
    Olsen A; Christensen J; Knudsen KE; Johnsen NF; Overvad K; Tjønneland A
    Breast Cancer Res Treat; 2011 Aug; 128(3):883-9. PubMed ID: 21340481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum enterolactone and prognosis of postmenopausal breast cancer.
    Buck K; Vrieling A; Zaineddin AK; Becker S; Hüsing A; Kaaks R; Linseisen J; Flesch-Janys D; Chang-Claude J
    J Clin Oncol; 2011 Oct; 29(28):3730-8. PubMed ID: 21900115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.
    Stattin P; Adlercreutz H; Tenkanen L; Jellum E; Lumme S; Hallmans G; Harvei S; Teppo L; Stumpf K; Luostarinen T; Lehtinen M; Dillner J; Hakama M
    Int J Cancer; 2002 May; 99(1):124-9. PubMed ID: 11948503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis.
    Seibold P; Vrieling A; Johnson TS; Buck K; Behrens S; Kaaks R; Linseisen J; Obi N; Heinz J; Flesch-Janys D; Chang-Claude J
    Int J Cancer; 2014 Aug; 135(4):923-33. PubMed ID: 24436155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma enterolactone and incidence of endometrial cancer in a case-cohort study of Danish women.
    Aarestrup J; Kyrø C; Knudsen KE; Weiderpass E; Christensen J; Kristensen M; Würtz AM; Johnsen NF; Overvad K; Tjønneland A; Olsen A
    Br J Nutr; 2013 Jun; 109(12):2269-75. PubMed ID: 23114205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma enterolactone and risk of colon and rectal cancer in a case-cohort study of Danish men and women.
    Johnsen NF; Olsen A; Thomsen BL; Christensen J; Egeberg R; Bach Knudsen KE; Loft S; Overvad K; Tjønneland A
    Cancer Causes Control; 2010 Jan; 21(1):153-62. PubMed ID: 19844797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma enterolactone and breast cancer risk in the Nurses' Health Study II.
    Xie J; Tworoger SS; Franke AA; Terry KL; Rice MS; Rosner BA; Willett WC; Hankinson SE; Eliassen AH
    Breast Cancer Res Treat; 2013 Jun; 139(3):801-9. PubMed ID: 23760859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers.
    Jaskulski S; Jung AY; Behrens S; Johnson T; Kaaks R; Thöne K; Flesch-Janys D; Sookthai D; Chang-Claude J
    Int J Cancer; 2018 Dec; 143(11):2698-2708. PubMed ID: 29974464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
    Olsen A; Knudsen KE; Thomsen BL; Loft S; Stripp C; Overvad K; Møller S; Tjønneland A
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2084-9. PubMed ID: 15598765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study.
    Vanharanta M; Voutilainen S; Lakka TA; van der Lee M; Adlercreutz H; Salonen JT
    Lancet; 1999 Dec 18-25; 354(9196):2112-5. PubMed ID: 10609816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota-derived metabolites and risk of coronary artery disease: a prospective study among US men and women.
    Liu G; Li J; Li Y; Hu Y; Franke AA; Liang L; Hu FB; Chan AT; Mukamal KJ; Rimm EB; Sun Q
    Am J Clin Nutr; 2021 Jul; 114(1):238-247. PubMed ID: 33829245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study.
    Vanharanta M; Voutilainen S; Rissanen TH; Adlercreutz H; Salonen JT
    Arch Intern Med; 2003 May; 163(9):1099-104. PubMed ID: 12742810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
    Piller R; Chang-Claude J; Linseisen J
    Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.
    Sonestedt E; Borgquist S; Ericson U; Gullberg B; Olsson H; Adlercreutz H; Landberg G; Wirfält E
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3241-51. PubMed ID: 18990767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An incident case-referent study on plasma enterolactone and breast cancer risk.
    Hultén K; Winkvist A; Lenner P; Johansson R; Adlercreutz H; Hallmans G
    Eur J Nutr; 2002 Aug; 41(4):168-76. PubMed ID: 12242585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum enterolactone concentrations are low in colon but not in rectal cancer patients.
    Tuomisto A; Nørskov NP; Sirniö P; Väyrynen JP; Mutt SJ; Klintrup K; Mäkelä J; Bach Knudsen KE; Mäkinen MJ; Herzig KH
    Sci Rep; 2019 Aug; 9(1):11209. PubMed ID: 31371751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.